市场调查报告书
商品编码
1390485
2023-2028 年肠溶软胶囊市场报告(按类型、应用、配销通路和地区)Enteric Softgel Capsules Market Report by Type, Application, Distribution Channel, and Region 2023-2028 |
2022年全球肠溶软胶囊市场规模达25亿美元。展望未来, IMARC Group预计到2028年市场规模将达到32亿美元,2022-2028年复合年增长率(CAGR)为4.20%。
肠溶软胶囊具有基于明胶的外壳涂层,内部含有半固体和液体药物。它们对消化液有抵抗力,因此可以不受影响地通过胃并溶解在肠道中。它们具有多种优点,例如生物利用度、易用性和提高的充分性水平。除此之外,它们还可以最大程度地减少不良余味,优化剂量效率,帮助治疗消化不良,并防止胃刺激和逆流。目前,人们对服用预防药物的好处的认识不断提高,刺激了全球对肠溶软胶囊的需求。
全球老年人口的不断增长,以及慢性疾病和营养缺乏性疾病盛行率的上升,是积极影响市场的关键因素之一。此外,个人健康意识的提高以及对营养和膳食补充剂的日益接受正在促进全球对肠溶软胶囊的需求。除此之外,製药业的显着成长以及 Omega-3 油和其他凝胶补充剂产品应用的不断扩大,带来了良好的市场前景。此外,推出非明胶肠溶软胶囊等产品创新正在加强市场的成长。此外,领先企业正专注于使用淀粉和其他有机植物来源来生产新品种,以满足纯素食消费者的需求。此外,药局的不断扩张以及透过电子商务零售管道的线上药局的激增正在为市场创造积极的前景。此外,领先的製药公司增加对研发(R&D)活动的投资以提高这些胶囊的生物利用度预计将推动市场成长。
The global enteric softgel capsules market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 4.20% during 2022-2028.
Enteric softgel capsules have gelatin-based shell coating with semi-solid and liquid medication inside. They are resistant to digestive juices and consequently pass through the stomach unaffected and dissolve in the intestinal tract. They provide several advantages, such as bioavailability, easy usability, and improved adequacy levels. Besides this, they minimize poor aftertaste, optimize dosage efficiency, help treat indigestion, and prevent gastric irritation and reflux. Presently, the increasing awareness among individuals about the benefits of consuming preventive medicines is catalyzing the demand for enteric softgel capsules worldwide.
The growing global geriatric population, along with the rising prevalence of chronic medical disorders and nutrient-deficient diseases, represents one of the key factors positively influencing the market. In addition, the rising health awareness among individuals and the growing acceptance of nutritional and dietary supplements are catalyzing the demand for enteric softgel capsules across the globe. Besides this, significant growth in the pharmaceutical industry and the expanding applications of the product to enclose omega-3 oils and other gel-based supplements are offering a favorable market outlook. Additionally, product innovations like the introduction of non-gelatin-based enteric softgel capsules are strengthening the growth of the market. In addition, leading players are focusing on manufacturing novel variants by using starch and other organic, plant-based sources to meet the requirements of vegan consumers. Furthermore, the growing expansion of pharmacies and the proliferation of online pharmacies through e-commerce retail channels are creating a positive outlook for the market. Moreover, increasing investments by leading pharma companies in research and development (R&D) activities to improve the bioavailability of these capsules are expected to propel market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global enteric softgel capsules market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and distribution channel.
Gelatin Capsules
Non-Gelatin Softgel Capsules
Gelatin capsules currently represent the largest market segment due to the increasing vegan population across the globe.
Health Supplements
Pharmaceuticals
Health supplements hold the majority of the global enteric softgel capsules market share due to the increasing usage of softgel capsules by fitness enthusiasts and rising awareness among individuals about nutraceutical supplements.
Supermarkets and Hypermarkets
Pharmacy and Drug Stores
Online Stores
Pharmacy and drug stores presently dominate the market on account of the increasing consumer preference to purchase medicinal products from registered pharmacies or drug stores.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market as healthcare providers are increasingly investing in research and development (R&D) activities to introduce effective treatment alternatives.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Aenova Group GmbH, BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsule Co., Ltd., Lonza Group AG, Now Health Group, Inc., ProCaps Group, Super Spectrim and Thermo Fisher Scientific, Inc.